• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酪氨酸激酶Src 是骨稳态的调节因子。

Tyrosine Kinase Src Is a Regulatory Factor of Bone Homeostasis.

机构信息

Division of Molecular Signaling and Biochemistry, Department of Health Improvement, Kyushu Dental University, Kitakyushu 803-8580, Japan.

出版信息

Int J Mol Sci. 2022 May 14;23(10):5508. doi: 10.3390/ijms23105508.

DOI:10.3390/ijms23105508
PMID:35628319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9146043/
Abstract

Osteoclasts, which resorb the bone, and osteoblasts, which form the bone, are the key cells regulating bone homeostasis. Osteoporosis and other metabolic bone diseases occur when osteoclast-mediated bone resorption is increased and bone formation by osteoblasts is decreased. Analyses of tyrosine kinase Src-knockout mice revealed that Src is essential for bone resorption by osteoclasts and suppresses bone formation by osteoblasts. Src-knockout mice exhibit osteopetrosis. Therefore, Src is a potential target for osteoporosis therapy. However, Src is ubiquitously expressed in many tissues and is involved in various biological processes, such as cell proliferation, growth, and migration. Thus, it is challenging to develop effective osteoporosis therapies targeting Src. To solve this problem, it is necessary to understand the molecular mechanism of Src function in the bone. Src expression and catalytic activity are maintained at high levels in osteoclasts. The high activity of Src is essential for the attachment of osteoclasts to the bone matrix and to resorb the bone by regulating actin-related molecules. Src also inhibits the activity of Runx2, a master regulator of osteoblast differentiation, suppressing bone formation in osteoblasts. In this paper, we introduce the molecular mechanisms of Src in osteoclasts and osteoblasts to explore its potential for bone metabolic disease therapy.

摘要

破骨细胞负责吸收骨骼,成骨细胞则负责形成骨骼,它们是调节骨骼内稳态的关键细胞。当破骨细胞介导的骨吸收增加,而成骨细胞形成的骨骼减少时,就会发生骨质疏松症和其他代谢性骨病。对酪酸激酶Src 敲除小鼠的分析表明,Src 对于破骨细胞的骨吸收是必需的,并且抑制成骨细胞的骨形成。Src 敲除小鼠表现出骨质增生。因此,Src 是骨质疏松症治疗的潜在靶点。然而,Src 在许多组织中广泛表达,并参与各种生物过程,如细胞增殖、生长和迁移。因此,开发针对 Src 的有效骨质疏松症治疗方法具有挑战性。为了解决这个问题,有必要了解 Src 在骨骼中的功能的分子机制。Src 的表达和催化活性在破骨细胞中维持在高水平。Src 的高活性对于破骨细胞附着在骨基质上以及通过调节与肌动蛋白相关的分子来吸收骨骼是必不可少的。Src 还抑制成骨细胞分化的主调控因子 Runx2 的活性,从而抑制成骨细胞中的骨形成。在本文中,我们介绍了 Src 在破骨细胞和成骨细胞中的分子机制,以探索其在骨代谢疾病治疗中的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210d/9146043/0475c48d1c57/ijms-23-05508-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210d/9146043/d659daa940f2/ijms-23-05508-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210d/9146043/2de5fa196a15/ijms-23-05508-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210d/9146043/0475c48d1c57/ijms-23-05508-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210d/9146043/d659daa940f2/ijms-23-05508-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210d/9146043/2de5fa196a15/ijms-23-05508-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210d/9146043/0475c48d1c57/ijms-23-05508-g003.jpg

相似文献

1
Tyrosine Kinase Src Is a Regulatory Factor of Bone Homeostasis.酪氨酸激酶Src 是骨稳态的调节因子。
Int J Mol Sci. 2022 May 14;23(10):5508. doi: 10.3390/ijms23105508.
2
WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.WHI-131 促进成骨细胞分化,防止破骨细胞形成和吸收在小鼠。
J Bone Miner Res. 2016 Feb;31(2):403-15. doi: 10.1002/jbmr.2612. Epub 2015 Aug 29.
3
Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling.蛋白激酶 N3 通过 Wnt5a-Ror2 信号促进破骨细胞的骨吸收。
Sci Signal. 2017 Aug 29;10(494):eaan0023. doi: 10.1126/scisignal.aan0023.
4
c-Src-Dependent and -Independent Functions of Matk in Osteoclasts and Osteoblasts.Matk 在破骨细胞和成骨细胞中的Src 依赖性和非依赖性功能。
J Immunol. 2018 Apr 1;200(7):2455-2463. doi: 10.4049/jimmunol.1700582. Epub 2018 Feb 12.
5
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice.选择性抑制Src 家族激酶 SU6656 通过促进骨形成与骨吸收解偶联增加小鼠骨量。
Bone. 2018 Aug;113:95-104. doi: 10.1016/j.bone.2018.05.006. Epub 2018 May 8.
6
The Actin-Binding Protein PPP1r18 Regulates Maturation, Actin Organization, and Bone Resorption Activity of Osteoclasts.肌动蛋白结合蛋白 PPP1r18 调控破骨细胞的成熟、肌动蛋白组织和骨吸收活性。
Mol Cell Biol. 2018 Jan 29;38(4). doi: 10.1128/MCB.00425-17. Print 2018 Feb 15.
7
Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts.在Src缺陷型或 tyrphostin A9处理的破骨细胞中,α(V)β(3)整合素及相关蛋白的异常定位和过度聚集。
J Cell Sci. 2001 Jan;114(Pt 1):149-160. doi: 10.1242/jcs.114.1.149.
8
GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass.G 蛋白偶联受体激酶 2 相互作用蛋白 1(GIT1)调节破骨细胞功能和骨量。
J Cell Physiol. 2010 Nov;225(3):777-85. doi: 10.1002/jcp.22282.
9
PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.PDK1 是 RANKL 诱导的破骨细胞形成和功能的重要脂质激酶,通过调节 Akt-GSK3β-NFATc1 信号级联。
J Cell Biochem. 2020 Nov;121(11):4542-4557. doi: 10.1002/jcb.29677. Epub 2020 Feb 12.
10
Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts.Src基因缺陷小鼠的骨质石化是由于破骨细胞的自主缺陷所致。
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4485-9. doi: 10.1073/pnas.90.10.4485.

引用本文的文献

1
Perfluoroalkyl Substance (PFAS) Mixtures Drive Rheumatoid Arthritis Risk Through Immunosuppression: Integrating Epidemiology and Mechanistic Evidence.全氟烷基物质(PFAS)混合物通过免疫抑制作用增加类风湿性关节炎风险:整合流行病学和机制证据
Int J Mol Sci. 2025 Aug 4;26(15):7518. doi: 10.3390/ijms26157518.
2
Direct and indirect effects of transforming growth factor-beta on osteoclast-mediated bone remodeling using a new in vitro bone matrix model.利用一种新的体外骨基质模型研究转化生长因子-β对破骨细胞介导的骨重塑的直接和间接影响。
JBMR Plus. 2025 Jun 13;9(8):ziaf104. doi: 10.1093/jbmrpl/ziaf104. eCollection 2025 Aug.
3
Exploration of Liuwei Dihuang Pill on periodontitis based on network pharmacology and molecular docking.

本文引用的文献

1
Protein phosphatase 1 regulatory subunit 18 suppresses the transcriptional activity of NFATc1 via regulation of c-fos.蛋白磷酸酶1调节亚基18通过调控c-fos抑制活化T细胞核因子c1的转录活性。
Bone Rep. 2021 Aug 4;15:101114. doi: 10.1016/j.bonr.2021.101114. eCollection 2021 Dec.
2
Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation.鉴定 c-Src 结构域中独特的功能对于破骨细胞足突带的形成是必需的。
J Biol Chem. 2021 Jan-Jun;296:100790. doi: 10.1016/j.jbc.2021.100790. Epub 2021 May 18.
3
c-Src kinase inhibits osteogenic differentiation via enhancing STAT1 stability.
基于网络药理学和分子对接技术探讨六味地黄丸治疗牙周炎的作用机制
Medicine (Baltimore). 2025 May 16;104(20):e42466. doi: 10.1097/MD.0000000000042466.
4
Inhibition of CD45-specific phosphatase activity restores the differentiation potential of aged mesenchymal stromal cells: implications in regenerative medicine.抑制CD45特异性磷酸酶活性可恢复衰老间充质基质细胞的分化潜能:对再生医学的启示
Biol Res. 2025 May 2;58(1):24. doi: 10.1186/s40659-025-00603-8.
5
Study on the mechanism of Shuanghe decoction against steroid-induced osteonecrosis of the femoral head: insights from network pharmacology, metabolomics, and gut microbiota.双合汤抗激素性股骨头坏死的作用机制研究:基于网络药理学、代谢组学和肠道微生物群的见解
J Orthop Surg Res. 2025 Feb 26;20(1):202. doi: 10.1186/s13018-025-05619-0.
6
Extracellular matrix: Dystroglycan interactions-Roles for the dystrophin-associated glycoprotein complex in skeletal tissue dynamics.细胞外基质:肌营养不良聚糖相互作用——肌营养不良蛋白相关糖蛋白复合物在骨骼组织动态中的作用
Int J Exp Pathol. 2025 Mar;106(2):e12525. doi: 10.1111/iep.12525.
7
Taste receptor type 1 member 3 in osteoclasts regulates osteoclastogenesis via detection of glucose.破骨细胞中的味觉受体1型成员3通过检测葡萄糖来调节破骨细胞生成。
J Biol Chem. 2025 Mar;301(3):108273. doi: 10.1016/j.jbc.2025.108273. Epub 2025 Feb 6.
8
Integrated approach with UHPLC-Q-Exactive-tandem mass spectrometry, network analysis, and molecular docking to determine potential active compounds and mechanisms of Rhizoma Musae decoction in osteoarthritis treatment.采用超高效液相色谱-四极杆-静电场轨道阱串联质谱联用、网络分析和分子对接的综合方法,以确定芭蕉根水煎剂治疗骨关节炎的潜在活性成分及作用机制。
Front Pharmacol. 2025 Jan 2;15:1380335. doi: 10.3389/fphar.2024.1380335. eCollection 2024.
9
The SRC/NF-κB-AKT/NOS3 axis as a key mediator of Kaempferol's protective effects against oxidative stress-induced osteoclastogenesis.SRC/NF-κB-AKT/NOS3 轴作为山奈酚对抗氧化应激诱导破骨细胞生成的保护作用的关键介质。
Immun Inflamm Dis. 2024 Oct;12(10):e70045. doi: 10.1002/iid3.70045.
10
Implication of CXCR2-Src axis in the angiogenic and osteogenic effects of FP-TEB.CXCR2-Src轴在FP-TEB血管生成和成骨作用中的意义
NPJ Regen Med. 2024 Sep 20;9(1):24. doi: 10.1038/s41536-024-00364-0.
c-Src 激酶通过增强 STAT1 稳定性来抑制成骨分化。
PLoS One. 2020 Nov 12;15(11):e0241646. doi: 10.1371/journal.pone.0241646. eCollection 2020.
4
The osteoclast cytoskeleton - current understanding and therapeutic perspectives for osteoporosis.破骨细胞细胞骨架——对骨质疏松症的当前认识及治疗前景
J Cell Sci. 2020 Jul 1;133(13):jcs244798. doi: 10.1242/jcs.244798.
5
Expression of a Constitutively Active Form of in Chondrocytes Activates Wnt and Hedgehog Signaling Pathways, and Induces Chondrocyte Proliferation in Mice.在软骨细胞中表达组成性激活形式的 可激活 Wnt 和 Hedgehog 信号通路,并诱导小鼠软骨细胞增殖。
Int J Mol Sci. 2020 Apr 12;21(8):2682. doi: 10.3390/ijms21082682.
6
Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas.Kif1c 作为 p130Cas 的下游分子调节破骨细胞的骨吸收。
Cell Biochem Funct. 2020 Apr;38(3):300-308. doi: 10.1002/cbf.3476. Epub 2019 Dec 30.
7
Plectin stabilizes microtubules during osteoclastic bone resorption by acting as a scaffold for Src and Pyk2.微丝联蛋白通过作为Src 和 Pyk2 的支架在破骨细胞骨吸收过程中稳定微管。
Bone. 2020 Mar;132:115209. doi: 10.1016/j.bone.2019.115209. Epub 2019 Dec 20.
8
The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition "Killing Two Birds with One Stone"?NF-κB 在生理骨骼发育和炎症性骨病中的作用:NF-κB 抑制是否“一石二鸟”?
Cells. 2019 Dec 14;8(12):1636. doi: 10.3390/cells8121636.
9
Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption.Vav1 抑制 RANKL 诱导的破骨细胞分化和骨吸收。
BMB Rep. 2019 Nov;52(11):659-664. doi: 10.5483/BMBRep.2019.52.11.013.
10
Suppression of hematopoietic cell kinase ameliorates the bone destruction associated with inflammation.抑制造血细胞激酶可改善炎症相关的骨质破坏。
Mod Rheumatol. 2020 Jan;30(1):85-92. doi: 10.1080/14397595.2018.1553266. Epub 2019 Jan 8.